QPSM was found to upregulate SERCA2a expression, reduce CaMKII oxidation, and decrease RyR2 phosphorylation levels, suggesting that QPSM alleviates diastolic calcium overload in cardiomyocytes while augmenting SR calcium reserves, thereby reducing AF susceptibility. This evidence concerns the gene RYR2 and atrial fibrillation.